Chemokine-derived peptides based on the N-terminal region sequences, such as T22, BKT140 (4F-benzoyl-TN14003), and CTCE-9908, prevented primary tumour growth and metastasis of melanoma, osteosarcoma, breast and prostate tumours through the inhibition of VEGF production, as well as inhibited angiogenesis and reduced recruitment of myeloid cells [127,128]. The gene discussed is VEGFA; the disease is neoplasm.